期刊文献+

右美托咪啶对机械性疼痛刺激的镇痛有效浓度测定 被引量:3

DETERMINATION OF EC_(50) OF DEXMEDETOMIDINE FOR PAIN RELIEF OF MECHANICAL STIMULUS IN VOLUNTEERS
下载PDF
导出
摘要 目的:测定右美托咪啶对志愿者机械性疼痛刺激的镇痛有效浓度.方法:征集健康志愿者50名(ASA-I级)随机分为5个组,每组10例,并接受机械性疼痛刺激和视觉模拟评分(visual analoguescale,VAS)分别以血浆靶浓度(0.9 ng/ml、1.04 ng/ml、1.2 ng/mi、1.39 ng/ml和1.6 ng/ml)靶控输注右美托咪啶,于靶控输注后5min (T1)、10min (T2)、15min (T3)、20min (T4)和30min (T5)等时点唤醒VAS评分,若唤醒困难或任何时间点VAS <10 mm为镇痛有效,并记录为阳性,并于相应时间点记录BIS值、HR、MAP和SpO2.采用概率单位法(probit)回归分析计算两组的浓度-效应曲线方程及其痛觉消失的EC50和EC95.结果:五组间随着靶浓度增加和时间推移,BIS值逐步下降,痛觉消失发生率逐渐上升(P<0.05).痛觉消失的EC50、EC9s分别为1.162(1.063~1.267) ng/ml和1.572(1.402~2.075) ng/ml.与基础值比较,各组MAP、HR于靶控输注10min时后开始逐渐下降(P<0.05).结论:DEX对机械性疼痛刺激具有明显的镇痛作用,EC50、EC95分别为1.162 ng/ml和1.572 ng/ml,合并血压和心率下降. Objective: To determine the median effective concentration (ECs0) of dexrnedetomidine for pain relief of mechanical stimulus in volunteers. Methods: Fifty volunteers (ASA-I) provided informed consent in the tests were randomly divided into 5 groups (10 in each group) according to different plasma concentrations of dexmedetomidine: 0.9 ng/ml (group D1), 1.04 ng/ml (group D2), 1.2 ng/ml (group D3), 1.39 ng/ml (group D4) and 1.6 ng/ml (group D5). The VAS pain scores were assessed by giving a vertically mechanical stimulus ( 150 g ) of electronic Von Frey on the palm of left hand. Dexmedetomidine was administered intravenously via a computer-controlled infusion pump as defined. The values of MAP (mean arterial pressure), HR (heart rate), SpO2 (pulse oxygen saturation) and BIS (bispectral index) and the VAS pain scores were repeatedly assessed every 5 minutes in 30 minutes after TCI began. If it was difficult to awake patient during sedation or the VAS pain scores were below 10 mm at any time points at 5 min, 10 rain, 15 min, 20 min, 25 min and 30 min, it was recorded as loss of pain effectively. A quantal response model (probit analysis) was used to calculate the concentration-effect curve and predict plasma ECs0 and EC95 of lOSS of pain of dexmedetomidine. Results: With increasing plasma concentration of dexmedetomidine and the time elapsed, the values of BIS decreased and the rate of pain relief increased gradually among the five groups (P 〈 0.05). EC50 and EC95 ofdexmedetomidine for loss of pain were 1.162 ( 1.063 ~ 1.267 ) ng/ml and 1.572 ( 1.402 ~ 2.075 ) ng/ml. Compared to the baseline values, the values of MAP and HR in each group decreased gradually beginning from 10 min after TCI began (P 〈 0.05 ) . Conclusion: Dexmedetomidine can relieve pain of mechanical stimulus with a concentration-response relationship, which was acompanied by hypotension and bradycardia during TCI. ECs0 and EC95 ofdexmedetomidine for loss of pain was 1.162 ng/ml and 1.572 ng/ml.
出处 《中国疼痛医学杂志》 CAS CSCD 北大核心 2014年第10期729-732,共4页 Chinese Journal of Pain Medicine
基金 广东省医学科研基金(项目编号:A2011477) 广州市医药卫生科研基金(项目编号:201102A213071)
关键词 右美托咪啶 靶控输注 机械性疼痛 镇痛 浓度-效应关系 Dexmedetomidine Target controlled infusion Mechanical pain Analgesia Concentration- response relationship
  • 相关文献

参考文献9

  • 1Chrysostomou C, Schmitt CG. Dexmedetomidine: sedation, analgesia and beyond. Expert opinion on drug metabolism & toxicology, 2008, 4:619 - 627.
  • 2Eisenach JC. a 2-agonists and analgesia. Exp Opin Invest Drugs, 1994, 3:1005 - 1010.
  • 3Ebert TJ, Hall JE, Barney JA, et al.The effects of incre- asing plasma concentrations of dexmedetomidine in humans. Anesthesiology, 2000, 93:382 - 394.
  • 4Angst MS, Ramaswamy B, DaviesMF, et al. Compar- ative analgesic andmental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans. Anesthesiology, 2004, 101:744 - 752.
  • 5邬子林,郭小花,郑彬,佘守章,许立新.靶控输注右美托咪啶对机械性疼痛刺激镇痛效果的观察[J].现代医院,2012,12(4):29-32. 被引量:5
  • 6Jaakola ML, Salonen M, Lehtinen R, et al. The analgesic action of dexmedetomidine-a novel a 2- adrenoceptor agonist-in healthy volunteers. Pain, 1991, 46:281 - 285.
  • 7Kodaka M, Okamoto Y, Koyama K, et al. Predicted values of propofol ECso and sevoflurane concentration for insertion of laryngeal mask Classic and ProSeal. Br J Anaesth, 2004, 92:242 -245.
  • 8Iannuzzi M, Iannuzzi E, Ressi F, et al. Relationship between bispectral in dex, electroencephalographic state entropy and effect-site EC50 for propofol at different clinical endpoints. Br J Anaesth, 2005, 94:492 : 495.
  • 9Bloor BC, Ward DS, Belleville JP, et al. Effects of intra- venous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology, 1992, 77:1134 - 1142.

二级参考文献10

  • 1CHRYSOSTOMOU C, SCHMITY CG. Dexmedetomidine : sedation, analgesia and beyond [ J ]. Expert opinion on drug metabolism & toxicology, 2008,4(5) :619 -627.
  • 2EISENACH JC. ot2 -agonists and analgesia[ J ]. Exp Opin Invest Drugs, 1994,3 : 1005 - 1010.
  • 3EBERT TJ, HALL J E, BARNEY J A, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans [ J ]. Anesthesiology, 2000,93 ( 2 ) : 382 - 394.
  • 4ANGST M S, RAMASWAMY B, DAVIESMF,et al. Comparative analgesic andmental effects of increasing plasma concentrations ofdexmedetomidine and alfentanil in humans [ J ]. Anesthesiology, 2004, 101 : 744 -752.
  • 5AANTAA R, JAAKOLA M L, KALLIO A, et al. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine [ J ]. Anesthesiology. 1997,86 (5) : 1055 - 1060.
  • 6EL - KERDAWY H, GOUDA N, KAMAL H. Dexmedetomidine as anaesthetic adjunct for patients undergoing of pump coronary artery bypass grafting [ J ]. Egyptian Journal of Anaesthesia, 2004,20 : 29 - 34.
  • 7HSU Y W, CORTINEZ L I, ROBERTSON KM,et al. Dexmedetomidine pharmacodynamics, part Ⅱ: crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers[J]. Anesthesiology,2004, 101 (7) : 1077 - 1083.
  • 8JAAKOLA M L, SALONEN M, LEHTINEN R,et al. The analgesic action of dexmedetomidine - a novelcd2 - adrenoceptor agonist - in healthy volunteers [ J ]. Pain, 1991,46 : 281 - 285.
  • 9KLAMT J G, ANDRADE VICENTE W V, GARCIA L V, et al. Effects of dexmedetomide - fentanyl infusion on blood Pressure and heart rate during cardiac surgery in children [ J ]. Anesthesiol Res Pract,2010,19(8) :311 -316.
  • 10LAUBIE M, SCHMITT H, VINCENT M. Vagal bradycardia produced by microinjections of morphine - like drugs into the nucleus ambiguous in anaesthetized dogs[J]. EurJ Pharmacol,1979, 59: 287 - 291.

共引文献4

同被引文献27

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部